DC’s top talent gathered on Friday at New York Comic-Con to discuss their plans for the future of DC’s All In. They discussed new… ...
ALBANY — Lilly Phillips began her college career as the lone freshman starter on a veteran-laden University at Albany women’s basketball team that won an America East Conference championship.
Seven actors have donned the cape and cowl across nearly 60 years of live-action Batman movies. From campy capers to noir-drenched crime thrillers, Batman has (to varying degrees of success ...
Eli Lilly's GLP-1 weight-loss drugs Mounjaro and Zepbound have been removed from the Food and Drug Administration's (FDA) shortage list.Yahoo Finance Senior Health Reporter Anjalee Khemlani ...
Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S. Food and Drug Administration (FDA) that competitor Eli Lilly’s obesity and diabetes drugs are no longer ...
DC Studios has tapped screenwriter Matthew Orton (“Captain America: Brave New World”) to write a feature film that will involve Batman villains Bane and Deathstroke, Variety has confirmed.
DC will be doing some back-breaking development work to bring these criminals to the big screen. By Borys Kit Senior Film Writer With a big-budget Joker movie just weeks away and a Penguin HBO ...
Holy Hollywood, Batman! The Caped Crusader of comic book, TV and film fame is set today to become the first superhero with a star on the Walk of Fame. The ceremony is set to begin at 11 a.m. in ...
Donanemab, manufactured by Eli Lilly (LLY), is the latest in a new class of anti-amyloid drugs that deliver antibodies to target beta-amyloid, a protein linked to Alzheimer's disease. Initially ...
The most recent trading session ended with Eli Lilly (LLY) standing at $909.32, reflecting a -1.65% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.4%.
It has been two years since the release of the latest Caped Crusader reboot, and The Batman was always intended to be the first movie in a new trilogy. As anticipation for the next installment ...